Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Dec 20, 2021
- Accession no.
- 0001209191-21-070707
- Filed
- Dec 20, 2021
- Trade date
- Dec 17, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $489.3K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 | Class A Common Stock | FTax withholdingDisposed | −5,082 | $92.00 | −$467,544 | 107,579 | Direct | |
| Dec 17, 2021 | Class A Common Stock | SSaleDisposed | −1,942 | $90.74F3 | −$176,217.08 | 30,324 | Indirect | |
| Dec 17, 2021 | Class A Common Stock | SSaleDisposed | −3,415 | $91.69F4 | −$313,121.35 | 26,909 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $90.17 to $91.05, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $91.48 to $91.88, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.